Geron News

MENLO PARK, Calif., February 8, 2012 - Geron Corporation today announced that John A. Scarlett, M.D., President and Chief Executive Officer, will present an overview of the company at 1:30 p.m. ET on Tuesday, February 14, 2012, at the 14th Annual BIO CEO & Investor Conference in New York City.

Just over a year ago, I gave the following interview regarding Geron . To be fair, the Geron I endorsed at that time was a very different company from the one which exists today.

MENLO PARK, Calif., February 2, 2012 - Geron Corporation today announced that the company has completed enrollment in the randomized Phase 2 clinical trial of imetelstat, in combination with paclitaxel, in patients with locally recurrent or metastatic breast cancer .

Greenwood, who had been with Geron in various jobs since 1995, left the Menlo Park-based drug development company at the end of last year.

A treatment for eye diseases that is derived from human embryonic stem cells might have improved the vision of two patients, bolstering the beleaguered field, researchers reported Monday.

Close to 1,100 of these puts were exchanged at the June 2 strike -- the majority of them at the ask price, suggesting they were purchased.